181 related articles for article (PubMed ID: 17140708)
1. Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
Mutwiri G; Benjamin P; Soita H; Townsend H; Yost R; Roberts B; Andrianov AK; Babiuk LA
Vaccine; 2007 Jan; 25(7):1204-13. PubMed ID: 17140708
[TBL] [Abstract][Full Text] [Related]
2. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
Shim DH; Ko HJ; Volker G; Potter AA; Mutwiri G; Babiuk LA; Kweon MN
Vaccine; 2010 Mar; 28(11):2311-7. PubMed ID: 20060944
[TBL] [Abstract][Full Text] [Related]
4. Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs.
Dar A; Lai K; Dent D; Potter A; Gerdts V; Babiuk LA; Mutwiri GK
Vet Immunol Immunopathol; 2012 May; 146(3-4):289-95. PubMed ID: 22377627
[TBL] [Abstract][Full Text] [Related]
5. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
[TBL] [Abstract][Full Text] [Related]
6. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene].
Andrianov AK; Marin A; Chen J
Biomacromolecules; 2006 Jan; 7(1):394-9. PubMed ID: 16398541
[TBL] [Abstract][Full Text] [Related]
8. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.
Payne LG; Jenkins SA; Woods AL; Grund EM; Geribo WE; Loebelenz JR; Andrianov AK; Roberts BE
Vaccine; 1998 Jan; 16(1):92-8. PubMed ID: 9607015
[TBL] [Abstract][Full Text] [Related]
9. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
11. Immune responses to in ovo vaccine formulations containing inactivated fowl adenovirus 8b with poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) and avian beta defensin as adjuvants in chickens.
Sarfraz M; Suleman M; Tikoo SK; Wheler C; Potter AA; Gerdts V; Dar A
Vaccine; 2017 Feb; 35(6):981-986. PubMed ID: 28087147
[TBL] [Abstract][Full Text] [Related]
12. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
13. Innate immune response profiles in pigs injected with vaccine adjuvants polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) and Emulsigen.
Magiri R; Lai K; Huang Y; Mutwiri G; Wilson HL
Vet Immunol Immunopathol; 2019 Mar; 209():7-16. PubMed ID: 30885308
[TBL] [Abstract][Full Text] [Related]
14. Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant.
Park SA; Song ES; Cho YJ; Ahn BY; Ha SH; Seong BL; Lee KH; Lee NG
Microbiol Immunol; 2007; 51(11):1099-107. PubMed ID: 18037787
[TBL] [Abstract][Full Text] [Related]
15. Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice.
Yam KK; Gupta J; Allen EK; Burt KR; Beaulieu É; Mallett CP; Burt DS; Ward BJ
Vaccine; 2016 Mar; 34(12):1444-51. PubMed ID: 26873056
[TBL] [Abstract][Full Text] [Related]
16. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re.
Song X; Chen J; Sakwiwatkul K; Li R; Hu S
Int Immunopharmacol; 2010 Mar; 10(3):351-6. PubMed ID: 20034596
[TBL] [Abstract][Full Text] [Related]
18. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
[TBL] [Abstract][Full Text] [Related]
19. A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
Hjertner B; Bengtsson T; Morein B; Paulie S; Fossum C
Vaccine; 2018 May; 36(23):3340-3344. PubMed ID: 29706292
[TBL] [Abstract][Full Text] [Related]
20.
Andrianov AK; Marin A; Wang R; Chowdhury A; Agnihotri P; Yunus AS; Pierce BG; Mariuzza RA; Fuerst TR
Mol Pharm; 2021 Feb; 18(2):726-734. PubMed ID: 32530637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
